Diffuse alveolar hemorrhage is a rare, life-threatening condition that can present suddenly in patients with diabetes and asthma exacerbation.
Answers are grounded in this paper and cite their sources.
Raises suspicion for diffuse alveolar hemorrhage in diabetic asthmatics with hemoptysis; single case leaves open questions on prevalence and management.
Diffuse alveolar hemorrhage (DAH) is a rare but potentially life-threatening condition characterized by bleeding into the alveolar spaces of the lungs. DAH can occur due to a wide range of etiologies including autoimmune diseases, infections, drugs, and malignancies. The clinical presentation is variable and may include cough, dyspnea, fever, and hemoptysis. Diagnosis is often challenging due to the nonspecific symptoms and a lack of definitive diagnostic criteria. Treatment is primarily aimed at addressing the underlying cause and providing supportive care.
No takes yet. Share an insight, caveat, or question.
Bardarov et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: